June 4

PARIS, June 4, 2011 - - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" - - Venous Thrombo-embolism Affects Up to 1 in 5 Cancer Patients And Chemotherapy Further Increases this Risk Sanofi (EURONEXT: SAN and NYSE: SNY) announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%[i], meeting the study primary endpoint (respectively 1.2% and 3.4% for semuloparin and placebo HR 0.36 95% CI (0.21-0.60)), p< 0.0001).

LONDON, June 4, 2010 - On June 5, Evgeny Lebedev will transform the grounds of his house in Hampton Court into a Russian church, with a bell tower and the roof of the temporary dining room based on that in St Basil's Cathedral.

LONDON, June 4, 2010 - Show and Stay have teamed up with Tesco Magazine to give away a fabulous 5-star theatre break.

LUXEMBOURG and DONGYING, China, June 4, 2010 - CNPV Solar Power SA, a leading integrated manufacturer of solar photovoltaic products, today announced the launch of the company's premium photovoltaic modules series with power ranging from 295Wp to 305Wp made with high efficiency 156x156mm mono crystalline cells for Utility scale applications.

AMSTERDAM, June 4, 2010 - SoGeo, provider of a context aware platform for mobile and web, today announced that it has secured EUR1M in funding.